News

July 8, 2020July 8, 2020

Foundation Offers Free Online Memory Screenings

News

To promote brain health, the Alzheimer’s Foundation of America (AFA) is offering free online memory screenings that people can participate in from home. The confidential screenings — part of ... Read more

July 6, 2020July 6, 2020

AlzeCure Announces Positive Data From Its First Clinical Study of ACD856

News

AlzeCure Pharma announced positive results from its first clinical study of ACD856 for the potential treatment of Alzheimer’s disease. According to the company, ACD856 showed a good pharmacokinetic profile ... Read more

July 1, 2020July 1, 2020

Amylyx Completes Enrollment in PEGASUS Trial of AMX0035 for Alzheimer’s

News

Amylyx Pharmaceuticals announced it has completed enrollment for the Phase 2 clinical trial of AMX0035 for treating Alzheimer’s disease. The placebo-controlled trial, PEGASUS (NCT03533257), will evaluate the compound’s safety and tolerability ... Read more

June 29, 2020June 29, 2020

Investigational Agitation Treatment AXS-05 Named FDA Breakthrough Therapy

News

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Axsome Therapeutics‘ AXS-05, an investigational oral therapy for the treatment of agitation in people with Alzheimer’s ... Read more

June 24, 2020June 24, 2020

Advanced Imaging Captures Protein Clumps in Neurons at Early Alzheimer Stages

News

Scientists used a new imaging technique to assess the structure of amyloid-beta aggregates — known culprits in Alzheimer’s development — that are present inside nerve cells at early stages of the disease, ... Read more

June 22, 2020June 22, 2020

Amyloid Clumps Formed on Space Station Affected by Microgravity

News

Experiments on the International Space Station showed gravity affects the formation of amyloids, the pathological tangles of proteins found in the brains of those with Alzheimer’s disease. Both the ... Read more

June 17, 2020June 17, 2020

Anavex 2-73 Trial for Early Alzheimer’s Expanded to Canada, UK

News

Anavex Life Sciences will expand its Phase 2b/3 clinical trial testing the efficacy and safety of Anavex 2-73 (blarcamesine) for the treatment of early Alzheimer’s disease into Canada and ... Read more

June 15, 2020June 15, 2020

Neurotrope Launches Long-term Trial of Bryostatin-1

News

Neurotrope has announced the launch of a Phase 2 clinical trial to investigate the long-term use of bryostatin-1 for moderate and moderately severe Alzheimer’s disease. The company expects to ... Read more

June 8, 2020June 8, 2020

‘The Longest Day’ Global Fundraiser Set for June 20

News

“The Longest Day” is the summer solstice — the day with the most light — which falls this year on June 20. It’s also the day each year that ... Read more

June 3, 2020June 3, 2020

Mouth Bacteria Can Infect Brain Cells, Research Finds, Supporting Alzheimer’s Link

News

A type of mouth bacteria involved in gum disease is able to infect human brain cells, new research shows. The infection results in cellular changes that are similar to ... Read more

Pin It on Pinterest